Senior Manager/Associate Director, Business Systems Coupa, Netsuite, etc Kura Oncology IncSenior Manager/Associate Director, Business Systems Coupa, Netsuite, etcBoston, MA$160,000–$186,000 / yearESSENTIAL JOB FUNCTIONS: The Senior Manager/Associate Director, Business Systems serves as the lead to Kura''s business platforms including but not limited to Finance, Procurement and Contracting applications, with primary ownership of the system operations, workflows, financial controls and related integrations, and future enterprise applications. Kura developed and is commercializing KOMZIFTI (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition.
Senior Director, Protein Analytics & Biophysics Generate Biomedicines IncSenior Director, Protein Analytics & BiophysicsSomerville, MA$210,000–$290,000 / yearSuccess in this role will require enterprise leadership: developing leaders and senior scientists, building an inclusive and high-accountability culture, partnering deeply across Protein Sciences, Prototyping, Technology, Data Sciences, Machine Learning, Biology, and CMC/Tech Ops, and translating an ambitious scientific vision into robust capabilities that improve decision quality, speed, and scale. The ideal candidate brings deep technical breadth, a quantitative mindset, and a clear point of view on how pooled assays, DNA/barcode-enabled readouts, synthetic biology, automation, microfluidics, advanced detection, and computational modeling can transform how protein therapeutics are evaluated.
Senior Manager/Associate Director, Biostatistics Beam TherapeuticsSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Senior Director, State Government Affairs Beam TherapeuticsSenior Director, State Government AffairsCambridge, MA$260,000–$320,000 / yearBeam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This individual will be responsible for building a variety of strong, meaningful networks at the state level (including State Medicaid officials, state legislators and state policy stakeholders) and staying current on critical policy issues.
Director, Biotherapeutic Production Technologies Generate Biomedicines IncDirector, Biotherapeutic Production TechnologiesAndover, MA$177,000–$250,000 / yearThe Role: Generate:Biomedicines is seeking an experienced and innovation-minded Director, Biotherapeutic Production Technologies, to define the strategy and lead the team responsible for protein expression, purification, and fit-for-purpose characterization in support of discovery and early development. The successful candidate will bring broad expertise across upstream expression and downstream purification, with particular strength in stable cell line technologies, vector and construct design, multi-gene expression, and the production of diverse or complex therapeutic protein modalities.
Director, Employee Communications & Engagement - Global Commercialization Argenx SEDirector, Employee Communications & Engagement - Global CommercializationBoston, MAargenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. Serve as a trusted advisor to Global Commercialization leaders, translating business priorities, growth strategies, and organizational change into compelling employee experiences and communications.
Associate Director, Investor Relations Beam TherapeuticsAssociate Director, Investor RelationsCambridge, MA$185,000–$225,000 / yearWork cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones; translate technical data into clear, investor-relevant narratives; and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution. You will partner closely with senior leadership, finance, legal, corporate communications, and program teams to translate complex clinical and scientific milestones into clear, compelling, investor-ready messaging across earnings cycles, conferences, and one-on-one engagements.
Associate Director, Treatment Center Quality Beam TherapeuticsAssociate Director, Treatment Center QualityCambridge, MA$185,000–$225,000 / yearBeam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. Qualification: Lead and manage both the onboarding and qualification process for new and existing commercial suppliers (e.g., treatment centers and transportation providers), including pre-classifications and quality system evaluations/reevaluations including identification of quality risks and development of mitigation strategies.
Senior Director, US EMPAVELI Brand Lead - Nephrology & Hematology Apellis Pharmaceuticals IncSenior Director, US EMPAVELI Brand Lead - Nephrology & HematologyWaltham, MA$234,000–$322,000 / yearExperience: 12+ years of biotech/pharma experience, predominantly in marketing roles of increasing scope and responsibility but also with experience in complementary commercial roles (e.g., patient & HCP marketing, sales, market access, commercial operations, global marketing, etc.). Cultivate collaboration and accountability across key cross-functional teams (home office and field leadership) to deliver on all elements of plans in a way that aligns with brand strategy and the corporate values / culture; drive a portfolio mindset among cross-functional leaders.
Associate Director, Bioanalytical Development Formation Bio IncAssociate Director, Bioanalytical DevelopmentBoston, MA$167,000–$230,000 / yearThe role will oversee external bioanalytical partners and drive execution for PK/TK, metabolites as applicable, biologics bioanalysis, and immunogenicity, including assay approach selection, validation strategy, sample analysis oversight, data review, and submission-ready documentation. The Associate Director, Bioanalytical will lead bioanalytical strategy and delivery for assigned programs, working across nonclinical and clinical teams to ensure assays are fit for purpose and support key development decisions.
Director, Business Development - Search & Evaluation Formation Bio IncDirector, Business Development - Search & EvaluationBoston, MA$228,000–$310,000 / yearLeading deal-by-deal opportunity/asset teams from asset identification to transaction close • Collaborating with the BD team to identify target areas for outreach, focusing on strategic alignment with Formation Bios goals • Owning and managing one or more designated business development outreach areas (e.g., big pharma, biotech companies, designated therapeutics areas) • Maximizing activity and ensuring high-quality deal flow in assigned outreach areas, developing a steady stream of opportunities • Conducting initial triage of opportunities, evaluating potential deals before engaging the broader diligence team to ensure strategic fit • Working cross-functionally with R&D, tech platform, and commercial teams to ensure smooth handoffs and successful transitions in the diligence process. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials.
Director, Global Indication Lead, Rheumatology Argenx SEDirector, Global Indication Lead, RheumatologyBoston, MARemote$196,000–$269,500 / yearargenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. Be the voice of the cross-functional Indication Commercialization Team (ICT) on the Indication Development Team (IDT), working closely with our Clinical Science and Development colleagues' to inform development strategy and efforts to maximize the value of our evidence generation efforts.